
Dali Pharmaceuticalco.,Ltd
SSE:603963.SS
1.18 (CNY) • At close February 11, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Dali Pharmaceuticalco.,Ltd |
Symbool | 603963.SS |
Munteenheid | CNY |
Prijs | 1.18 |
Beurswaarde | 259,246,000 |
Dividendpercentage | 0% |
52-weken bereik | 1.18 - 15.97 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Jun Xiang Yang |
Website | https://www.daliyaoye.cn |
An error occurred while fetching data.
Over Dali Pharmaceuticalco.,Ltd
Dali Pharmaceuticalco.,Ltd researches, develops, produces, and sells pharmaceutical products in China. It develops Chinese and Western medicine injection products of 20 varieties with 44 specifications of the injection drug approval number. The company's products include xingnaojing, shenmai, and astragalus injections, as well as leucocin A and citicoline injections. It also
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)